Shiskabill $OCAT official 60 persons, 3 cohort AMD trial https://clinicaltrials.gov/ct2/show/NCT02563782?term=MA09-hRPE&rank=8 Sham Comparator: Control group Sham surgery and placebo immunosuppressive therapy (IMT) Drug: Placebo tacrolimus and mycophenolate mofetil Procedure: Sham Surgery Active Comparator: Active Group Sub-retinal transplantation of MA09-hRPE cells and IMT Biological: Sub-retinal transplantation of MA09-hRPE cells Drug: tacrolimus and mycophenolate mofetil Immunosuppressive Agents The amount of RPEs will be 200K.